Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Budigalimab in Adult Participants Living With Human Immunodeficiency Virus (HIV)

North TX Infectious Diseases /ID# 224494, Dallas

Ruane Clinical Research Group /ID# 224496, Los Angeles

Franco Felizarta, Md /Id# 223931, Bakersfield

Quest Clinical Research /ID# 223925, San Francisco

Central Texas Clinical Research /ID# 223937, Austin

St. Hope Foundation, Inc. /ID# 224492, Bellaire

The Crofoot Research Center, Inc /ID# 224493, Houston

Peter Shalit, M.D. /ID# 224801, Seattle

Ponce Medical School Foundation /ID# 224230, Ponce

Puerto Rico AIDS Clinical Trials Unit CRS /ID# 223936, San Juan